Market Research Logo

Global IoT in Healthcare Market Report Insights, Opportunity Analysis, Market Shares and Forecast, 2017 - 2023

Global IoT in Healthcare Market Report Insights, Opportunity Analysis, Market Shares and Forecast, 2017 - 2023

Internet of things is one of the most promising technologies that has the potential to improve health care system. IOT in healthcare provides several benefits such as improved user experience, improved quality of care, reduced cost of care, disease management in real time and improved patient outcome.The significant reason behind integrating IOT features in the medical devices is to enhance the quality and service of care for patients with chronic conditions. These days hospitals are implementing smart beds which are able todetect when a patient has left and when the beds are occupied. OBRC analysis estimates that global IOT healthcare market to grow at CAGR 30.80% during the forecast period 2016-2023. The major factors driving the IoT healthcare market are, increase in investment for healthcare IOT solutions and rising penetration of connected devices in healthcare. Howeverincreasing adoption of telepresence technology and high potential in emerging economies is creating opportunities for the IOT healthcare market.

Global IOT healthcare market is divided into 3 segments component, application and end-user. Report further covers segments of component type which includes medical devices, systems and software and services. The software segment is anticipated to be the largest share in the global market in 2016 due to rising adoption of healthcare IT solutions.The application segment is divided into telemedicine clinical operation and workflow management, connected imaging, impatient monitoring and medication management. The end-user segment comprises of 3 sub segments which clinical research organisation, hospitals, surgical centre, clinics and research & diagnostic laboratories. . The hospitals, surgical centres, and clinics segment is the dominating segment in the forecast period.

North America had the highest revenue share in 2016due to the rising in the healthcare market. Moreover there is a large amount of spending in healthcare IT by United States and Canada for the management of chronic diseasesand increase in investments and government initiatives in the healthcare sector which is driving the market in North America. Asia pacific IOT healthcare market is expected to record a significant growth due to various factors such as growing demand for quality healthcare.are increasing focus towards safe, quality, and equitable healthcare services in a cost-effective manner.

The key players of the IOT healthcare market globally includesMedtronic PLC (U.S.), Cisco Systems, Inc. (U.S.), Royal Philips (Netherlands), IBM Corporation (U.S.), Stanley Healthcare (U.S.) , Qualcomm Life, Inc. (U.S.), SAP SE (Germany), Honeywell Life Care Solutions (U.S.).These key players are adopting various strategies such as mergers acquisitions, product launch, partnership and agreement to strengthen their position across the globe.

Please note: The delivery time for the electronic version of this report is between 1-3 business days to allow the preparation of an updated version prior to dispatch.


1. Introduction
1.1. EXECUTIVE SUMMARY
1.2. ESTIMATION METHODOLOGY
2. MARKET OVERVIEW
2.1. GLOBAL IOT HEALTHCAREMARKET: EVOLUTION & TRANSITION
2.2. MARKET DEFINITION & SCOPE
2.3. INDUSTRY STRUCTURE
2.4. TOTAL MARKET ANALYSIS
2.4.1. TOP 5 FINDINGS
2.4.2. TOP 5 OPPORTUNITY MARKETS
2.4.3. TOP 5 COMPANIES
2.4.4. TOP 3 COMPETITIVE STRATEGIES
2.5. ESTIMATION ANALYSIS
2.6. STRATEGIC ANALYSIS
2.6.1. INVESTMENT VS. ADOPTION MODEL
2.6.2. 360 DEGREE INDUSTRY ANALYSIS
2.6.3. PORTERS 5 FORCE MODEL
2.6.4. SEE-SAW ANALYSIS
2.6.5. ROI ANALYSIS
2.6.6. CONSUMER ANALYSIS AND KEY BUYING CRITERIA
2.7. COMPETITIVE ANALYSIS
2.7.1. KEY STRATEGIES & ANALYSIS
2.7.2. MARKET SHARE ANALYSIS&TOP COMPANY ANALYSIS
2.8. STRATEGIC RECOMMENDATIONS & KEY CONCLUSIONS
2.8.1. INVESTMENT OPPORTUNITIES BY REGIONS
2.8.2. OPPORTUNITIES IN EMERGING APPLICATIONS
2.8.3. INVESTMENT OPPORTUNITY IN FASTEST GROWING SEGMENT
3. MARKET DETERMINANTS
3.1. MARKET DRIVERS
3.1.1. REDUCED COST OF PATIENT CARE
3.1.2. EVOLUTION OF ARTIFICIAL INTELLIGENCE TECHNOLOGY
3.1.3. INCREASE IN INVESTMENT FOR HEALTHCARE IOT SOLUTIONS
3.1.4. RISING PENETRATION OF CONNECTED DEVICES IN HEALTHCARE
3.2. MARKET RESTRAINTS
3.2.1. LACK OF COMPETENCE IN DEPLOYING IOT SOLUTIONS
3.2.2. LACK OF GOVERNANCE STANDARDS
3.3. MARKET OPPORTUNITIES
3.3.1. INCREASING ADOPTION OF TELEPRESENCE TECHNOLOGY
3.3.2. HIGH POTENTIAL IN EMERGING ECONOMIES
3.4. MARKET CHALLENGES
3.4.1. INCREASING INTEROPERABILITY RISKS
3.4.2. LACK OF AWARENESS AMONG CONSUMERS IN DEVELOPING REGIONS
4. MARKET SEGMENTATION
4.1. GLOBAL IOT HEALTHCAREMARKET BY COMPONENT
4.1.1. MARKET DEFINITION AND SCOPE
4.1.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.1.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.1.4. OPPORTUNITY MATRIX
4.1.5. MARKET SEGMENTATION
4.1.5.1. GLOBAL MEDICAL DEVICESMARKET
4.1.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.5.1.3. KEY PLAYERS & KEY PRODUCTS
4.1.5.1.4. KEY CONCLUSIONS
4.1.5.2. GLOBAL SYSTEM AND SOFTWARE MARKET
4.1.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.5.2.3. KEY PLAYERS & KEY PRODUCTS
4.1.5.2.4. KEY CONCLUSIONS
4.1.5.3. GLOBAL SERVICES MARKET
4.1.5.3.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.3.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.5.3.3. KEY PLAYERS & KEY PRODUCTS
4.1.5.3.4. KEY CONCLUSIONS
4.2. GLOBAL IOT HEALTHCAREMARKET BY APPLICATIONS
4.2.1. MARKET DEFINITION AND SCOPE
4.2.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.2.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.2.4. OPPORTUNITY MATRIX
4.2.5. MARKET SEGMENTATION
4.2.5.1. GLOBALTELEMEDICINEMARKET
4.2.5.1.1. APPLICATION
4.2.5.1.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.1.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.2.5.1.4. KEY PLAYERS & KEY PRODUCTS
4.2.5.1.5. KEY CONCLUSIONS
4.2.5.2. GLOBAL CLINICAL OPERATIONS AND WORKFLOW MANAGEMENTMARKET
4.2.5.2.1. APPLICATION
4.2.5.2.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.2.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.2.5.2.4. KEY PLAYERS & KEY PRODUCTS
4.2.5.2.5. KEY CONCLUSIONS
4.2.5.3. GLOBAL CONNECTED IMAGING MARKET
4.2.5.3.1. APPLICATION
4.2.5.3.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.3.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.2.5.3.4. KEY PLAYERS & KEY PRODUCTS
4.2.5.3.5. KEY CONCLUSIONS
4.2.5.4. GLOBAL MEDICATION MANAGEMENT MARKET
4.2.5.4.1. APPLICATION
4.2.5.4.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.4.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.2.5.4.4. KEY PLAYERS & KEY PRODUCTS
4.2.5.4.5. KEY CONCLUSIONS
4.2.5.5. GLOBAL IN-PATIENT MONITORING MARKET
4.2.5.5.1. APPLICATION
4.2.5.5.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.5.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.2.5.5.4. KEY PLAYERS & KEY PRODUCTS
4.2.5.5.5. KEY CONCLUSIONS
4.3. GLOBAL IOT HEALTHCAREMARKET BY ENDUSER
4.3.1. MARKET DEFINITION AND SCOPE
4.3.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.3.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.3.4. OPPORTUNITY MATRIX
4.3.5. MARKET SEGMENTATION
4.3.5.1. GLOBAL HOSPITALS SURGICALS AND CLINICS
4.3.5.1.1. APPLICATION
4.3.5.1.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.5.1.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.3.5.1.4. KEY PLAYERS & KEY PRODUCTS
4.3.5.1.5. KEY CONCLUSIONS
4.3.5.2. GLOBAL CLINICAL RESEARCH ORGANISATIONS
4.3.5.2.1. APPLICATION
4.3.5.2.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.5.2.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.3.5.2.4. KEY PLAYERS & KEY PRODUCTS
4.3.5.2.5. KEY CONCLUSIONS
4.3.5.3. GLOBAL RESEARCH AND DIAGNISTIC LABORATORIES
4.3.5.3.1. APPLICATION
4.3.5.3.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.5.3.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.3.5.3.4. KEY PLAYERS & KEY PRODUCTS
4.3.5.3.5. KEY CONCLUSIONS
5. COMPETITIVE LANDSCAPE
5.1. KEY STRATEGIES
5.1.1. LIST OF MERGER & ACQUISITION
5.1.2. LIST OF JOINT VENTURE
5.1.3. LIST OF PRODUCT LAUNCHES
5.1.4. LIST OF PARTNERSHIP
5.2. TOP 10 COMPANY ANALYSIS
6. GEOGRAPHICAL ANALYSIS
6.1. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
6.2. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
6.3. OPPORTUNITY MATRIX
6.4. GLOBAL IOT HEALTHCAREMARKET BY REGION 2014-2023 ($ MILLION)
6.4.1. NORTH AMERICA
6.4.1.1. INDUSTRY ANALYSIS 2014-2023 ($ MILLION)
6.4.1.2. TOP COUNTRY ANALYSIS
6.4.1.2.1. U.S.
6.4.1.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.1.2.1.2. KEY PLAYERS & KEY PRODUCTS
6.4.1.2.1.3. KEY CONCLUSIONS
6.4.1.2.2. CANADA
6.4.1.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.1.2.2.2. KEY PLAYERS & KEY PRODUCTS
6.4.1.2.2.3. KEY CONCLUSIONS
6.4.2. EUROPE
6.4.2.1. INDUSTRY ANALYSIS 2014-2023 ($ MILLION)
6.4.2.2. TOP COUNTRY ANALYSIS
6.4.2.2.1. UK
6.4.2.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.1.2. KEY PLAYERS & KEY PRODUCTS
6.4.2.2.1.3. KEY CONCLUSIONS
6.4.2.2.2. FRANCE
6.4.2.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.2.2. KEY PLAYERS & KEY PRODUCTS
6.4.2.2.2.3. KEY CONCLUSIONS
6.4.2.2.3. GERMANY
6.4.2.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.3.2. KEY PLAYERS & KEY PRODUCTS
6.4.2.2.3.3. KEY CONCLUSIONS
6.4.2.2.4. RUSSIA
6.4.2.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.4.2. KEY PLAYERS & KEY PRODUCTS
6.4.2.2.4.3. KEY CONCLUSIONS
6.4.2.2.5. REST OF EUROPE
6.4.2.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.5.2. KEY PLAYERS & KEY PRODUCTS
6.4.2.2.5.3. KEY CONCLUSIONS
6.4.3. ASIA PACIFIC
6.4.3.1. INDUSTRY ANALYSIS 2014-2023 ($ MILLION)
6.4.3.2. TOP COUNTRY ANALYSIS
6.4.3.2.1. CHINA
6.4.3.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.1.2. KEY PLAYERS & KEY PRODUCTS
6.4.3.2.1.3. KEY CONCLUSIONS
6.4.3.2.2. INDIA
6.4.3.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.2.2. KEY PLAYERS & KEY PRODUCTS
6.4.3.2.2.3. KEY CONCLUSIONS
6.4.3.2.3. JAPAN
6.4.3.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.3.2. KEY PLAYERS & KEY PRODUCTS
6.4.3.2.3.3. KEY CONCLUSIONS
6.4.3.2.4. AUSTRALIA
6.4.3.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.4.2. KEY PLAYERS & KEY PRODUCTS
6.4.3.2.4.3. KEY CONCLUSIONS
6.4.3.2.5. REST OF ASIA PACIFIC
6.4.3.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.5.2. KEY PLAYERS & KEY PRODUCTS
6.4.3.2.5.3. KEY CONCLUSIONS
6.4.4. ROW
6.4.4.1. INDUSTRY ANALYSIS 2014-2023 ($ MILLION)
6.4.4.2. TOP COUNTRY ANALYSIS
6.4.4.2.1. LATIN AMERICA
6.4.4.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.4.2.1.2. KEY PLAYERS & KEY PRODUCTS
6.4.4.2.1.3. KEY CONCLUSIONS
6.4.4.2.2. MIDDLE EAST & AFRICA
6.4.4.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.4.2.2.2. KEY PLAYERS & KEY PRODUCTS
6.4.4.2.2.3. KEY CONCLUSIONS
7. COMPANY PROFILES
7.1. GE HEALTHCARE LTD. (U.S.)
7.1.1. OVERVIEW
7.1.2. PRODUCT PORTFOLIO
7.1.3. STRATEGIC INITIATIVES
7.1.4. SCOT ANALYSIS
7.1.5. STRATEGIC ANALYSIS
7.2. MEDTRONIC PLC. (U.S.)
7.2.1. OVERVIEW
7.2.2. PRODUCT PORTFOLIO
7.2.3. STRATEGIC INITIATIVES
7.2.4. SCOT ANALYSIS
7.2.5. STRATEGIC ANALYSIS
7.3. CISCO SYSTEMS INC. . (U.S)
7.3.1. OVERVIEW
7.3.2. PRODUCT PORTFOLIO
7.3.3. STRATEGIC INITIATIVES
7.3.4. SCOT ANALYSIS
7.3.5. STRATEGIC ANALYSIS
7.4. INTERNATIONAL BUSINESS MACHIENE (U.S.)
7.4.1. OVERVIEW
7.4.2. PRODUCT PORTFOLIO
7.4.3. STRATEGIC INITIATIVES
7.4.4. SCOT ANALYSIS
7.4.5. STRATEGIC ANALYSIS
7.5. MICROSOFT CORPORATION(U.S.)
7.5.1. OVERVIEW
7.5.2. PRODUCT PORTFOLIO
7.5.3. STRATEGIC INITIATIVES
7.5.4. SCOT ANALYSIS
7.5.5. STRATEGIC ANALYSIS
7.6. HONEYWELL LIFE CARE SOLUTIONS (U.S.)
7.6.1. OVERVIEW
7.6.2. PRODUCT PORTFOLIO
7.6.3. STRATEGIC INITIATIVES
7.6.4. SCOT ANALYSIS
7.6.5. STRATEGIC ANALYSIS
7.7. KONINKLIJKE PHILIPS N.V (NETHERLAND )
7.7.1. OVERVIEW
7.7.2. PRODUCT PORTFOLIO
7.7.3. STRATEGIC INITIATIVES
7.7.4. SCOT ANALYSIS
7.7.5. STRATEGIC ANALYSIS
7.8. QUALCOMM LIFE INC. (U.S.)
7.8.1. OVERVIEW
7.8.2. PRODUCT PORTFOLIO
7.8.3. STRATEGIC INITIATIVES
7.8.4. SCOT ANALYSIS
7.8.5. STRATEGIC ANALYSIS
7.9. PROTEUS DIGITAL HEALTH INC.(U.S.)
7.9.1. OVERVIEW
7.9.2. PRODUCT PORTFOLIO
7.9.3. STRATEGIC INITIATIVES
7.9.4. SCOT ANALYSIS
7.9.5. STRATEGIC ANALYSIS
7.10. ALPHABET INC.(U.S.)
7.10.1. OVERVIEW
7.10.2. PRODUCT PORTFOLIO
7.10.3. STRATEGIC INITIATIVES
7.10.4. SCOT ANALYSIS
7.10.5. STRATEGIC ANALYSIS
7.11. APPLE INC. (U.S.)
7.11.1. OVERVIEW
7.11.2. PRODUCT PORTFOLIO
7.11.3. STRATEGIC INITIATIVES
7.11.4. SCOT ANALYSIS
7.11.5. STRATEGIC ANALYSIS
7.12. SAP SE (GERMANY)
7.12.1. OVERVIEW
7.12.2. PRODUCT PORTFOLIO
7.12.3. STRATEGIC INITIATIVES
7.12.4. SCOT ANALYSIS
7.12.5. STRATEGIC ANALYSIS
7.13. STANLEY HEALTHCARE (U.S.)
7.13.1. OVERVIEW
7.13.2. PRODUCT PORTFOLIO
7.13.3. STRATEGIC INITIATIVES
7.13.4. SCOT ANALYSIS
7.13.5. STRATEGIC ANALYSIS
7.14. ROYAL PHILIPS(NETHERLANDS)
7.14.1. OVERVIEW
7.14.2. PRODUCT PORTFOLIO
7.14.3. STRATEGIC INITIATIVES
7.14.4. SCOT ANALYSIS
7.14.5. STRATEGIC ANALYSIS
7.15. ST. JUDE MEDICAL INC.(U.S.)
7.15.1. OVERVIEW
7.15.2. PRODUCT PORTFOLIO
7.15.3. STRATEGIC INITIATIVES
7.15.4. SCOT ANALYSIS
7.15.5. STRATEGIC ANALYSIS
LIST OF TABLES
GLOBAL IOT HEALTHCAREMARKET BY COMPONENET ($ MILLION)
GLOBAL MEDICAL DEVICES MARKET BY GEOGRAPHY ($ MILLION)
GLOBAL SYSTEMS AND SOFTWARE MARKET BY GEOGRAPHY ($ MILLION)
GLOBAL SERVICES MARKET BY GEOGRAPHY ($ MILLION)
GLOBAL IOT HEALTHCAREMARKET BY APPLICATIONS ($ MILLION)
GLOBAL TELEMEDICINE MARKETBY GEOGRAPHY ($ MILLION)
GLOBAL CLINICAL OPERATIONS AND WORK FLOW MANAGEMENT MARKET BY GEOGRAPHY ($ MILLION)
GLOBAL CONNECTED IMAGING MARKET BY GEOGRAPHY ($ MILLION)
GLOBAL IMPATIENT MONITORING BY GEOGRAPHY($ MILLION)
GLOBAL MEDICATION MANAGEMENT BY GEOGRAPHY($ MILLION)
GLOBAL IOT HEALTHCAREMARKET BY ENDUSER($ MILLION)
GLOBAL HOSPITALS CLINICS SURGICAL CENTERS MARKET BY GEOGRAPHY($ MILLION)
GLOBAL RESEARCH AND DIAGONISTIC LABORATORIES HEALTHCARE MARKET BY GEOGRAPHY($ MILLION)
GLOBAL CLINICAL RESEARCH ORGANISATIONS MARKET BY GEOGRAPHY($ MILLION)
NORTH AMERICA IOT HEALTHCAREMARKET ($ MILLION)
EUROPE IOT HEALTHCAREMARKET ($ MILLION)
ASIA PACIFIC IOT HEALTHCAREMARKET ($ MILLION)
REST OF THE WORLD IOT HEALTHCAREMARKET ($ MILLION)
LIST OF FIGURES
GLOBAL MEDICAL DEVICES MARKET ($ MILLION)
GLOBAL SYSTEMS AND SOFTWAREMARKET ($ MILLION)
GLOBAL SERVICES MARKET ($ MILLION)
GLOBAL TELEMEDICINESMARKET ($ MILLION)
GLOBAL CLINICAL OPERATIONS AND WORKFLOW MANAGEMENT MARKET ($ MILLION)
GLOBAL CONNECTED IMAGING MARKET ($ MILLION)
GLOBAL IMPATIENT MONITORINGMARKET ($ MILLION)
GLOBAL MEDICATION MANAGEMENT MARKET($ MILLION)
GLOBAL HOSPITALS SURGICAL CENTERS AND CLINICS MARKET($ MILLION)
GLOBAL CLINICAL RESEARCH ORGANISATION MARKET($ MILLION)
GLOBAL RESEARCH AND DIAGONISTIC LABORATORIES MARKET($ MILLION)
UNITED STATES (U.S.) IOT HEALTHCAREMARKET ($ MILLION)
CANADA IOT HEALTHCAREMARKET ($ MILLION)
UNITED KINGDOM (UK) IOT HEALTHCAREMARKET ($ MILLION)
FRANCE IOT HEALTHCARE MARKET ($ MILLION)
GERMANY IOT HEALTHCARE MARKET ($ MILLION)
RUSSIA IOT HEALTHCARE MARKET ($ MILLION)
ROE IOT HEALTHCARE MARKET ($ MILLION)
INDIA IOT HEALTHCARE MARKET ($ MILLION)
CHINA IOT HEALTHCARE MARKET ($ MILLION)
JAPAN IOT HEALTHCARE MARKET ($ MILLION)
AUSTRALIAIOT HEALTHCARE MARKET ($ MILLION)
ROAPAC IOT HEALTHCARE MARKET ($ MILLION)
LATIN AMERICA IOT HEALTHCARE MARKET ($ MILLION)
MENA IOT HEALTHCARE MARKET 2014-2023 ($ MILLION)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report